PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Apr-2024 Single Use Cystoscope Market Forecasted to Surpass USD 191 Million by 2033 | Market.us Wired Release
24-Apr-2024 Medical Devices Vigilance Market to Reach USD 174.2 Billion by 2033 | Market.us Wired Release
24-Apr-2024 Bone Replacement Market Anticipated to Grow at 5.7% CAGR, Reaching USD 29.9 Billion by 2033 Wired Release
24-Apr-2024 Paper Diagnostics Market Anticipated to Grow at 8.4% CAGR, Reaching USD 21.1 Billion by 2033 Wired Release
24-Apr-2024 Frankincense Essential Oil Market To Cross to US$ USD 588 Million in Revenues by 2033 | CAGR of 7.7% Wired Release
24-Apr-2024 CDMO Live: New Event Launched To Accelerate, De-Carbonise and Optimise Contract Manufacturing PharmaSource / Life Science Networks
24-Apr-2024 Dr. Amir Bajoghli Receives Top Doctor Award 2024 in Dermatology by Northern Virginia Magazine AccessWire
24-Apr-2024 Moderna and OpenAI Collaborate To Advance mRNA Medicine AccessWire
24-Apr-2024 Vytalize Health Announces Key Leadership Additions to Support Continued Excellence in Value-Based Care AccessWire
24-Apr-2024 Clearstep Partners with Ochsner Health to Tackle Healthcare Access and Capacity Challenges AccessWire
24-Apr-2024 CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update AccessWire
24-Apr-2024 CureVac Appoints Thaminda Ramanayake as New Chief Business Officer AccessWire
24-Apr-2024 CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK AccessWire
24-Apr-2024 Senzime publishes annual and sustainability report for 2023 AccessWire
24-Apr-2024 CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update CureVac
24-Apr-2024 CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK CureVac
24-Apr-2024 CureVac Appoints Thaminda Ramanayake as New Chief Business Officer CureVac
24-Apr-2024 Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission AccessWire
24-Apr-2024 Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement AccessWire
24-Apr-2024 BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer BeiGene